KZ

Kai Zhang

Chief Executive Officer

MingSight Pharmaceuticals

Therapeutic Areas

MingSight Pharmaceuticals Pipeline

DrugIndicationPhase
MS-553Diabetic Macular Edema (DME) / Diabetic Retinopathy (DR)Phase 1b/2